Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LITAF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TFDP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHTF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAMD9L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF135 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100996792 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VDAC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TXNRD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AURKB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AP1S2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101930343 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
GRN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C19orf60 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RTKN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALDOA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCNE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GBP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFIB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on